Inge Grondman
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Immunology top 10%
- Immune responses and vaccinations
- Complement system in diseases
- Immune Response and Inflammation
Papers in
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 2
-
- Immune cells in cancer 3
- Immune responses and vaccinations 3
- Inflammation biomarkers and pathways 2
- Immune Response and Inflammation 2
- Co-authors
- Mihai Gheorghe Netea (16 shared papers)Matthijs Kox (8 shared papers)Peter Pickkers (8 shared papers)Aline de Nooijer (10 shared papers)Mihai I. Ioana (2 shared papers)Frank L. van de Veerdonk (8 shared papers)Nico A. F. Janssen (8 shared papers)Anca Lelia Riza (2 shared papers)
- Journals
- Frontiers in Immunology (3 papers)The Journal of Infectious Diseases (2 papers)Critical Care (2 papers)Nature Communications (1 paper)Nature Immunology (1 paper)
- Partner nations
- NetherlandsGermanyRomania
In The Last Decade
Inge Grondman
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 389
- Immunology 250
- Epidemiology 283
- Applied Microbiology and Biotechnology 16
- Aging 11
Countries citing papers authored by Inge Grondman
This map shows the geographic impact of Inge Grondman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Grondman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Grondman more than expected).
Fields of papers citing papers by Inge Grondman
This network shows the impact of papers produced by Inge Grondman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Grondman. The network helps show where Inge Grondman may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge Grondman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 123 | |
| 2 | 2020 | 114 | |
| 3 | 2020 | 108 | |
| 4 | 2022 | 106 | |
| 5 | 2020 | 105 | |
| 6 | 2020 | 96 | |
| 7 | 2021 | 69 | |
| 8 | 2021 | 58 | |
| 9 | 2020 | 51 | |
| 10 | 2019 | 39 | |
| 11 | 2023 | 39 | |
| 12 | 2021 | 38 | |
| 13 | 2021 | 30 | |
| 14 | 2022 | 24 | |
| 15 | 2025 | 21 | |
| 16 | 2022 | 20 | |
| 17 | 2021 | 19 | |
| 18 | 2022 | 16 | |
| 19 | 2022 | 15 | |
| 20 | 2022 | 13 |
About Inge Grondman
Inge Grondman is a scholar working on Infectious Diseases, Immunology, Epidemiology, Applied Microbiology and Biotechnology and Cell Biology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Sepsis Diagnosis and Treatment (8 papers), Immune cells in cancer (3 papers), Immune responses and vaccinations (3 papers), Inflammation biomarkers and pathways (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Immune Response and Inflammation (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (1 paper). The work is most often cited by research in Infectious Diseases (389 citations), Immunology (250 citations), Epidemiology (283 citations), Applied Microbiology and Biotechnology (16 citations) and Aging (11 citations). Inge Grondman has collaborated with scholars based in Netherlands, Germany and Romania. Frequent co-authors include Mihai Gheorghe Netea, Matthijs Kox, Peter Pickkers, Aline de Nooijer, Mihai I. Ioana, Frank L. van de Veerdonk, Nico A. F. Janssen, Anca Lelia Riza, Leo A. B. Joosten and Emma J. Kooistra. Their work appears in journals such as Frontiers in Immunology, The Journal of Infectious Diseases, Critical Care, Nature Communications and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.